Biotech Stocks Alert | Open Your Eyes & Ears for (OXIS)

biotech stocks OXIS

GT Biopharma (OXIS) is now something that a lot of you have become familiar with. The latest announcement from (OXIS) is centered around the upcoming conference call, which will be hosting. Keep in mind that not only does this come after the recent surge in trading but also following the company’s most recent announcements. These include the addition of new patients to the company’s Phase 2 FDA trials as well as the previously announced agreement to acquire Georgetown Translational Pharmaceuticals Inc.

Knowing what we know now about the proposed acquisition, this could be a vital next step for all who are following (OXIS). The company will be hosting a conference call to go into the details of its latest developments at 4:15pm EST on Wednesday, August 16, 2017. The dial in number for the call is 712-775-7031. Meeting ID number is 576-591-822.

We’ve seen (OXIS) scramble to new highs over the last week and based on the market activity, that may be just the beginning. What we could be seeing right now is a new support level that is roughly 50% higher than where it was just a few weeks ago. (OXIS) has been a proven runner in the past and now that the company has begun to expand with its latest acquisition, there could be real, near-term opportunity for the company considering what Georgetown Translational is bringing to the table.

If you have not done so, take a close look at (OXIS) because this could be just the beginning of the next move for a previous 400% biotech runner. CLICK NOW TO DOWNLOAD FULL REPORT


Please enter your name here
Please enter your comment!